ALL HOSPITALS | ALL SPECIALTIES
ONE WEEK DATA COLLECTION
GlobalSurg | CovidSurg Week is an international prospective multi-centre cohort study that aims:
(1) To determine the optimal timing of surgery following SARS-CoV-2 infection;
(2) Determine assess key global surgical indicators, such as postoperative mortality.
All hospitals can participate in this study, including hospitals that have not admitted SARS-CoV-2 infected patients.
All patients (from all specialties) undergoing a surgical procedure done in an operating theatre will be included (any SARS-CoV-2 status).
All collaborators will be included as PubMed-citable co-authors on resulting publications.
GlobalSurg | CovidSurg Week documents
Country specific GlobalSurg | CovidSurg Week documents
To participate in GlobalSurg | CovidSurg Week you must first secure research/audit approval, according to local regulations. Once the study is approved, you can upload the data to the online REDCap database. Please use the links below to find multi language translations and study approvals from the countries taking part.
Country specific GlobalSurg | CovidSurg Week translations
Please find below the French protocol for use ONLY outside of France
Country specific GlobalSurg | CovidSurg Week approvals
Please find below all the documents you need to start study approval process: